Silk Road Medical Inc Quarterly Operating Income (Loss) in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Silk Road Medical Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2018 to Q2 2024.
  • Silk Road Medical Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$17.2M, a 20.1% decline year-over-year.
  • Silk Road Medical Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$60.2M, a 13.4% decline year-over-year.
  • Silk Road Medical Inc annual Operating Income (Loss) for 2023 was -$59.3M, a 14% decline from 2022.
  • Silk Road Medical Inc annual Operating Income (Loss) for 2022 was -$52M, a 9.56% decline from 2021.
  • Silk Road Medical Inc annual Operating Income (Loss) for 2021 was -$47.5M, a 10.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$60.2M -$17.2M -$2.88M -20.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$57.3M -$14.9M +$1.98M +11.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 -$59.3M -$14.4M -$1.74M -13.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$57.5M -$13.7M -$4.45M -48.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$53.1M -$14.3M -$122K -0.86% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$53M -$16.9M -$956K -5.99% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$52M -$12.6M +$1.43M +10.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$53.4M -$9.23M +$4.07M +30.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$57.5M -$14.2M -$4.24M -42.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$53.3M -$16M -$5.79M -57% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$47.5M -$14.1M +$930K +6.2% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$48.4M -$13.3M -$3.96M -42.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$44.4M -$9.95M -$559K -5.95% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$43.9M -$10.2M -$1.02M -11.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$42.9M -$15M -$7.49M -99.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$35.4M -$9.33M -$1.94M -26.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$33.4M -$9.39M -$3.38M -56.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 -$30.1M -$9.14M -$1.99M -27.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$28.1M -$7.51M -$208K -2.85% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$27.9M -$7.4M -$2.71M -57.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$25.1M -$6.02M -$1.25M -26.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$23.9M -$7.15M -$2.5M -53.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$21.4M -$7.3M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 -$4.68M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$4.77M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$4.65M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.